Welcome to our dedicated page for Pure Bioscience news (Ticker: PURE), a resource for investors and traders seeking the latest updates and insights on Pure Bioscience stock.
PURE Bioscience, Inc. (OTCQB: PURE) is a manufacturing company focused on antimicrobial technology for food safety and the food and beverage industry. Its news flow centers on the development, commercialization, and distribution of products built on its patented, stabilized ionic silver platform, particularly silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent.
News updates for PURE often include financial results for fiscal quarters and years, where the company reports net product sales, royalty revenue, gross profit, operating expenses, and net loss. These releases also discuss trends in sales across direct customers and distribution networks, as well as efforts to manage operating costs and secure financing through convertible notes payable to related parties.
Another key category of PURE news involves product and technology developments. The company has announced an SDC-based membrane treatment solution for dairy and beverage producers, using its PURE Hard Surface product to address membrane fouling and sanitization in ultrafiltration and reverse osmosis systems. Updates describe performance attributes such as microbial reduction, restoration of throughput, and non-oxidizing behavior, along with pilot work at a California State University Dairy Pilot Processing Center.
PURE also issues news about distribution agreements and partnerships, such as multi-year arrangements with Hydrite Chemical Company and Bonsai, which expand access to its EPA-registered disinfectants, cleaners, and sanitizers across food processing, dairy, transportation, and online channels. Additional releases cover corporate developments, including leadership changes, rebranding initiatives, and proxy-related matters disclosed through SEC filings. Investors and industry observers can use the PURE news feed to follow the company’s operational performance, market expansion efforts, and strategic direction in antimicrobial and sanitation technologies.
PURE Bioscience (OTCQB: PURE) reported financial results for fiscal Q1 2025 ended October 31, 2024. Net product sales decreased to $555,000 from $718,000 in the same quarter last year, primarily due to budgetary constraints of a major customer. The company's net loss improved slightly to $689,000 compared to $735,000 in Q1 2024. Net loss per share remained stable at ($0.01).
CEO Robert Bartlett noted that while the company continues to develop its business strategy with key distributors, the process is taking longer than expected. PURE is investing resources in onboarding new distributors, training, and marketing initiatives to expand their product offerings across the food and beverage industry.
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with AFCO, a Zep Company, for their patented SDC (silver dihydrogen citrate) antimicrobial products. The strategic partnership aims to leverage AFCO's extensive network in the food and beverage sector. SDC technology offers a dual-action antimicrobial solution with a unique shelf life of several years, unlike traditional silver-based disinfectants that last only hours to days. The collaboration focuses on expanding product applications and providing innovative solutions throughout North America.
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with Quip Laboratories for its patented SDC (silver dihydrogen citrate) antimicrobial products. The partnership aims to enhance product accessibility across biomedical research, pharmaceutical production, companion animal care, and food processing industries. SDC's dual-action antimicrobial technology works by deactivating membrane proteins and denaturing DNA in microbes, offering a stable shelf life of several years compared to traditional silver-based disinfectants.
PURE Bioscience (OTCQB: PURE) reported fiscal year 2024 results with net product sales of $1.955M, up from $1.871M in 2023. The company reduced its net loss to $3.4M from $3.9M year-over-year, with net loss per share improving to ($0.03) from ($0.04). Cash used in operations decreased to $2.5M from $3.3M. During Q2 2024, PURE shifted its strategy from end-use customers to a distribution model, establishing multiple distributor partnerships across the US. The company is developing new Clean-in-Place solutions and focusing on innovation in food safety through collaborations with academia and distribution network scientists.
PURE Bioscience, Inc. (OTCQB: PURE) has entered into a multi-year distribution agreement with Madison Chemical Co., Inc. for the purchase and selling of SDC (silver dihydrogen citrate) products. This strategic partnership aims to expand the availability of PURE's innovative antimicrobial solutions in the food processing industry.
Tim Steffensmeier, VP of Sales at PURE, expressed excitement about the collaboration, highlighting Madison Chemical's expertise and loyal customer base as key factors in enhancing PURE's distribution capabilities. Andrew Sims, VP of Sales at Madison Chemical, emphasized the partnership's potential to leverage industry knowledge and meet growing demands in food processing.
The press release also explains how SDC works, noting its dual action mechanism that makes it highly effective against a broad spectrum of microbes. Unlike traditional silver-based disinfectants with short shelf lives, SDC offers a stable solution with a shelf life of several years.
PURE Bioscience, Inc. (OTCQB: PURE) has entered into a multi-year distribution agreement with Tennessee-based Zee Company to purchase and sell PURE's patented antimicrobial products. This partnership allows PURE, the creator of non-toxic Silver Dihydrogen Citrate (SDC) antimicrobials, to sell its products to Zee Company and its clients under special terms.
Zee Company, a member of the Vincit Group, brings over 50 years of expertise in chemical blending, laboratory services, food safety, and cleaning practices. The collaboration aims to deliver exceptional value and set new industry standards in the food and beverage sector.
PURE's SDC technology offers a dual-action antimicrobial solution that kills microorganisms by deactivating membrane proteins and denaturing DNA. Unlike traditional silver-based disinfectants with short shelf lives, SDC remains stable for several years, making it highly effective against a broad spectrum of microbes.
PURE Bioscience, Inc. (OTCQB: PURE) has entered into a multi-year distribution agreement with ChemStation Buyers Association, Inc. for the purchase and selling of SDC (silver dihydrogen citrate) products. This partnership aligns with ChemStation's commitment to delivering safe and effective custom cleaning solutions with environmental consideration.
SDC, PURE's patented non-toxic antimicrobial, kills microorganisms through two modes of action: deactivating structural and metabolic membrane proteins and denaturing DNA within the microbe. This dual action makes SDC highly effective against a broad spectrum of microbes. Unlike traditional silver-based disinfectants with short shelf lives, SDC remains stable for several years, offering a unique advantage in the antimicrobial market.
PURE Bioscience will unveil its newest food safety solutions at the 2024 International Association for Food Protection (IAFP) show in Long Beach, California, from July 14th-17th, 2024. The company specializes in non-toxic, chlorine-free food safety products using its patented silver dihydrogen citrate (SDC) molecule. Key products include PURE® Hard Surface, a disinfectant that eliminates bacteria like Listeria and E. coli in 30 seconds, and PURE Control®, an antimicrobial aid for produce and poultry. The event will feature various solutions aimed at improving food safety and sanitation without harmful chemicals.
PURE Bioscience has signed a multi-year international supply and license agreement with AgroVet Alliance. This partnership will see the distribution of PURE's patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial products across the Middle East and North Africa. Jeff Kitchell, VP of Operations at PURE, highlighted the strategic fit between PURE's vision and AVA's established network in the animal health sector. AVA's CEO, Nick Nikooforsat, expressed excitement about offering SDC products to their network, emphasizing the potential business impact for their customers. SDC stands out due to its dual-action mechanism, effectively killing a broad spectrum of microbes and having a long shelf life, unlike traditional silver-based disinfectants.
PURE Bioscience reported its fiscal Q3 2024 financial results, highlighting a net product sales increase to $440,000 from $406,000 YoY, and a reduced net loss of $857,000 from $876,000 YoY. For the nine months ending April 30, 2024, net product sales were up to $1,483,000 from $1,269,000 YoY, with net loss decreasing to $2,594,000 from $2,929,000 YoY. The company is transitioning from a direct sales model to a distributor model, developing new pricing agreements, boosting social media engagement by 167%, and increasing followers by 70%. They continue to participate in trade shows and expand R&D efforts, focusing on food safety and environmental sustainability in industries like dairy and animal health.